Stay updated on JCAR017 Safety & Pharmacokinetics in B-cell NHL Clinical Trial
Sign up to get notified when there's something new on the JCAR017 Safety & Pharmacokinetics in B-cell NHL Clinical Trial page.

Latest updates to the JCAR017 Safety & Pharmacokinetics in B-cell NHL Clinical Trial page
- CheckyesterdayChange DetectedDifference0.2%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.4%
- Check15 days agoChange DetectedDifference0.4%
- Check23 days agoChange DetectedThe webpage has undergone significant content changes, including the removal of detailed descriptions of a Phase 1 study for JCAR017, which evaluated its safety and efficacy in treating various types of B-cell non-Hodgkin lymphoma. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference34%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.2%
- Check37 days agoChange DetectedThe page has been updated to reflect a change in terminology from 'Lymphosarcoma' to 'B-cell Lymphoma' and has been revised from version 2.14.2 to 2.14.3.SummaryDifference0.4%
Stay in the know with updates to JCAR017 Safety & Pharmacokinetics in B-cell NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JCAR017 Safety & Pharmacokinetics in B-cell NHL Clinical Trial page.